• A few already existing projects will be rolled into Life Sciences, including its smart contact lenses research, as well as nanoparticles that can be used to detect and fight cancer. Life Sciences will also head up the study looking to create the richest portrait yet of the human body and genome.
  • Unsurprisingly, Life Sciences will be headed by Andy Conrad, who was previously in charge of Google Life Sciences. This isn't a big jump for Google, but it shows why it thought it needed a new parent company -- life sciences work is less connected to Google's internet bread and butter. Calico will remain an independent company.
  • From Brin's post: "They’ll continue to work with other life sciences companies to move new technologies from early stage R&D to clinical testing—and, hopefully—transform the way we detect, prevent, and manage disease... The team is relatively new but very diverse including software engineers, oncologists, and optics experts."

Share This Article